[ medicaldecision ]
Why choosing medicaldecision?
Health economics and outcomes research. If the analysis of cost versus effectiveness (CEA) including modeling or outcomes research is the objective of your research project, qualified support is offered.
The appropriate market access strategy is critical for wide patient access and optimal reimbursement of your medicinal product in your market. Experienced support in developing your access strategy under the German AMNOG process is part of my portfolio.
After several years working for global players in the pharmaceutical industry in various positions in Medical Affairs and Market Access, I offer my expertise as a freelace consultant for the success of your projects and work assignements.
[ ABOUT ]
Who is medicaldecision?
medicaldecision is a consultant service in Medical affairs and HEOR
provided by Conrad Fischer, PharmD, MPH
[ SERVICES ]
and CEA Modeling
Consultant Information Officer (Informationsbeauftragter n. §74a AMG)
[ CONTACT ME ]
Are you interested in my services or would like to receive a copy of my CV?
[ FIND US ]
medicaldecision is located in Munich/Germany